BUB1 and neuroblastoma: Results from three data sets all suggested that patients with high bub1 expression had lower overall survival rates (Figures 1A, E, G) and recurrence-free survival rates (Figures 1B, F, H) than those with low bub1 expression, implicating a potential role of bub1 as a prognostic biomarker for patients with neuroblastoma.